Copy of newspaper publication dated May 30, 2026 regarding publication of extract of Audited Financial Results (Standalone and Consolidated) for Quarter and Year ended 31st March, 2026.
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anlon Healthcare Ltd published audited financial results (standalone and consolidated) for Q4 and FY ended March 31, 2026, via newspaper advertisement on May 30, 2026. Total income from operations stood at Rs. 5,088.91 lakhs (consolidated Q4) and Rs. 17,196.56 lakhs (consolidated FY). Consolidated profit after tax for the year was Rs. 2,908.72 lakhs, with other comprehensive income adding Rs. 35.59 lakhs, bringing total comprehensive income to Rs. 2,944.31 lakhs. EPS (basic & diluted) was Rs. 6.37 for the year on a face value of Rs. 10 per share. Paid-up equity share capital is Rs. 5,315.15 lakhs, and reserves (excluding revaluation reserve) grew to Rs. 20,977.27 lakhs from Rs. 4,057.52 lakhs in the previous year. The board meeting to approve these results was held on May 29, 2026.
Strong FY2025-26 performance with nearly 47% YoY revenue growth and solid profitability. The sharp increase in reserves indicates substantial retained earnings accumulation, which is positive for long-term shareholders. The stock is listed on BSE (scrip code: 544497) and NSE (scrip code: AHCL).